BlackRock’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $38.6M | Buy |
4,145,303
+80,427
| +2% | +$700K | ﹤0.01% | 2686 |
|
|
2025
Q4 | $30.5M | Buy |
4,064,876
+195,746
| +5% | +$1.99M | ﹤0.01% | 2830 |
|
|
2025
Q3 | $33.6M | Sell |
3,869,130
-141,625
| -4% | -$846K | ﹤0.01% | 2764 |
|
|
2025
Q2 | $14.9M | Sell |
4,010,755
-536,397
| -12% | -$1.89M | ﹤0.01% | 3189 |
|
|
2025
Q1 | $14.7M | Sell |
4,547,152
-374,169
| -8% | -$1.76M | ﹤0.01% | 3107 |
|
|
2024
Q4 | $27.4M | Buy |
4,921,321
+52,532
| +1% | +$412K | ﹤0.01% | 2841 |
|
|
2024
Q3 | $52.6M | Sell |
4,868,789
-28,108
| -0.6% | -$466K | ﹤0.01% | 2442 |
|
|
2024
Q2 | $103M | Buy |
4,896,897
+612,349
| +14% | +$15.4M | ﹤0.01% | 2013 |
|
|
2024
Q1 | $137M | Buy |
4,284,548
+819,961
| +24% | +$20.9M | ﹤0.01% | 1881 |
|
|
2023
Q4 | $70.2M | Buy |
3,464,587
+340,911
| +11% | +$4.49M | ﹤0.01% | 2290 |
|
|
2023
Q3 | $39.8M | Buy |
3,123,676
+209,246
| +7% | +$3.5M | ﹤0.01% | 2532 |
|
|
2023
Q2 | $52.7M | Buy |
2,914,430
+363,695
| +14% | +$6.7M | ﹤0.01% | 2447 |
|
|
2023
Q1 | $43.8M | Buy |
2,550,735
+42,103
| +2% | +$819K | ﹤0.01% | 2533 |
|
|
2022
Q4 | $55.7M | Buy |
2,508,632
+278,233
| +12% | +$4.3M | ﹤0.01% | 2389 |
|
|
2022
Q3 | $17.9M | Buy |
2,230,399
+47,641
| +2% | +$431K | ﹤0.01% | 3097 |
|
|
2022
Q2 | $15.2M | Buy |
2,182,758
+52,532
| +2% | +$511K | ﹤0.01% | 3249 |
|
|
2022
Q1 | $32.2M | Buy |
2,130,226
+42,544
| +2% | +$668K | ﹤0.01% | 2862 |
|
|
2021
Q4 | $45.8M | Buy |
2,087,682
+649,319
| +45% | +$15.9M | ﹤0.01% | 2711 |
|
|
2021
Q3 | $38.8M | Buy |
1,438,363
+706,953
| +97% | +$20.2M | ﹤0.01% | 2831 |
|
|
2021
Q2 | $17.6M | Buy |
731,410
+184,006
| +34% | +$5.63M | ﹤0.01% | 3380 |
|
|
2021
Q1 | $23.7M | Buy |
547,404
+541,476
| +9,134% | +$24M | ﹤0.01% | 3088 |
|
|
2020
Q4 | $246K | Buy |
+5,928
| New | +$245K | ﹤0.01% | 4445 |
|
Other funds holding FDMT
RCM
NHAS
BI
VCM
AC
